Omega Healthcare Investors (NYSE:OHI) Rating Increased to Moderate Buy at Raymond James Financial

Raymond James Financial upgraded shares of Omega Healthcare Investors (NYSE:OHIFree Report) to a moderate buy rating in a report published on Tuesday,Zacks.com reports.

Other analysts have also issued research reports about the company. Royal Bank Of Canada boosted their price target on Omega Healthcare Investors from $47.00 to $48.00 and gave the company a “sector perform” rating in a research note on Monday, May 4th. Weiss Ratings lowered Omega Healthcare Investors from a “buy (b+)” rating to a “buy (b)” rating in a research note on Tuesday. Bank of America reissued an “underperform” rating and issued a $46.00 price objective (down from $52.00) on shares of Omega Healthcare Investors in a research note on Tuesday, April 14th. BMO Capital Markets reissued a “market perform” rating and issued a $52.00 price objective on shares of Omega Healthcare Investors in a research note on Monday, May 4th. Finally, Wells Fargo & Company boosted their price objective on Omega Healthcare Investors from $47.00 to $49.00 and gave the stock an “equal weight” rating in a research note on Monday, June 1st. Five research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $49.08.

Check Out Our Latest Report on Omega Healthcare Investors

Omega Healthcare Investors Price Performance

Shares of OHI stock opened at $44.70 on Tuesday. The stock’s fifty day simple moving average is $46.39 and its 200 day simple moving average is $45.73. The company has a debt-to-equity ratio of 0.81, a current ratio of 5.32 and a quick ratio of 5.32. The firm has a market cap of $13.31 billion, a price-to-earnings ratio of 21.59, a P/E/G ratio of 1.94 and a beta of 0.58. Omega Healthcare Investors has a one year low of $35.70 and a one year high of $49.33.

Omega Healthcare Investors (NYSE:OHIGet Free Report) last announced its quarterly earnings results on Tuesday, April 28th. The real estate investment trust reported $0.47 EPS for the quarter, missing the consensus estimate of $0.49 by ($0.02). The company had revenue of $322.96 million during the quarter, compared to analyst estimates of $264.07 million. Omega Healthcare Investors had a net margin of 51.14% and a return on equity of 11.86%. Omega Healthcare Investors’s quarterly revenue was up 16.7% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.75 EPS. Omega Healthcare Investors has set its FY 2026 guidance at 3.190-3.250 EPS. On average, analysts expect that Omega Healthcare Investors will post 3.1 earnings per share for the current fiscal year.

Omega Healthcare Investors Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, May 15th. Stockholders of record on Monday, May 4th were paid a dividend of $0.67 per share. This represents a $2.68 annualized dividend and a dividend yield of 6.0%. The ex-dividend date of this dividend was Monday, May 4th. Omega Healthcare Investors’s dividend payout ratio is 129.47%.

Hedge Funds Weigh In On Omega Healthcare Investors

Large investors have recently made changes to their positions in the company. BNP Paribas Financial Markets increased its holdings in Omega Healthcare Investors by 91.9% in the fourth quarter. BNP Paribas Financial Markets now owns 389,305 shares of the real estate investment trust’s stock valued at $17,262,000 after purchasing an additional 186,399 shares during the last quarter. CPC Advisors LLC bought a new stake in Omega Healthcare Investors in the fourth quarter valued at about $3,050,000. JPMorgan Chase & Co. increased its holdings in Omega Healthcare Investors by 77.9% in the third quarter. JPMorgan Chase & Co. now owns 3,417,240 shares of the real estate investment trust’s stock valued at $144,278,000 after purchasing an additional 1,496,059 shares during the last quarter. Bright Futures Wealth Management LLC. bought a new stake in Omega Healthcare Investors in the third quarter valued at about $458,000. Finally, Pensionfund PDN bought a new stake in Omega Healthcare Investors in the fourth quarter valued at about $2,053,000. Institutional investors and hedge funds own 65.25% of the company’s stock.

About Omega Healthcare Investors

(Get Free Report)

Omega Healthcare Investors, Inc is a real estate investment trust (REIT) that specializes in the ownership and management of healthcare-related facilities. The company’s core business involves acquiring and leasing long-term care properties, including skilled nursing facilities and assisted living communities, under net lease agreements. Its portfolio is designed to provide stable, inflation-protected cash flows from operators responsible for day-to-day property management.

Founded in 1992 and headquartered in Hunt Valley, Maryland, Omega Healthcare Investors has grown its holdings to encompass hundreds of facilities across the United States, with a smaller presence in select international markets.

See Also

Analyst Recommendations for Omega Healthcare Investors (NYSE:OHI)

Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.